Immunotherpy

#Artificial intelligence (AI) #Cancer research #Immunotherpy #Oncology #Radiopharmaceuticals #Therapeutic Antibodies

What lies ahead in cancer research?

Megan Thomas comments and speaks with experts to uncover the future of cancer research. Artificial intelligence (AI) It’s not whether AI should be used, it’s when and how. Until several hurdles are overcome, such as data quality, data privacy and security, as well as regulatory and ethical challenges, this is… Read More

#Cancer Research #Exclusive Content

Cancer cells
#Funding #Immunotherpy #NeoPhore #Proteins #Small molecules

Financing extension for neoantigen immuno-oncology company 

NeoPhore has announced a further extension of £9.6 million (approximately $12.2 million) to its Series B financing round, bringing the total raised to £31.1 million (approximately $39.5 million).  The company is building a pipeline of small molecule drugs targeting novel proteins across the DNA mismatch repair (MMR)… Read More

#Business & Investment #Cancer Research #News